Chemical formula: C₃₂H₄₀BrN₅O₅ Molecular mass: 654.595 g/mol PubChem compound: 31101
Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G02CB01 | Bromocriptine | G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors |
| N04BC01 | Bromocriptine | N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| PARLODEL Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Bromocriptine is an active ingredient of these brands:
Australia (AU)
Brazil (BR)
Cyprus (CY)Estonia (EE)
France (FR)
Hong Kong (HK)
Ireland (IE)
Italy (IT)
Japan (JP)
Netherlands (NL)
Romania (RO)
Singapore (SG)South Africa (ZA)
Spain (ES)
Tunisia (TN)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
